Detalles de la búsqueda
1.
Tributylhexadecylphosphonium bromide, a novel nuclear factor of activated T cells signaling inhibitor, blocks interleukin-2 induction associated with inhibition of p70 ribosomal protein S6 kinase phosphorylation.
Biol Pharm Bull
; 35(5): 805-9, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22687422
2.
KW-2449, a novel multikinase inhibitor, suppresses the growth of leukemia cells with FLT3 mutations or T315I-mutated BCR/ABL translocation.
Blood
; 114(8): 1607-17, 2009 Aug 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-19541823
3.
Novel and orally active 5-(1,3,4-oxadiazol-2-yl)pyrimidine derivatives as selective FLT3 inhibitors.
Bioorg Med Chem Lett
; 18(20): 5472-7, 2008 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18835166
4.
A novel FLT3 inhibitor FI-700 selectively suppresses the growth of leukemia cells with FLT3 mutations.
Clin Cancer Res
; 13(15 Pt 1): 4575-82, 2007 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17671144
5.
Preclinical and phase I clinical studies of KW-2450, a dual IGF-1R/IR tyrosine kinase inhibitor, in combination with lapatinib and letrozole.
Ther Adv Med Oncol
; 10: 1758835918786858, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30083253
6.
Epirubicin, Identified Using a Novel Luciferase Reporter Assay for Foxp3 Inhibitors, Inhibits Regulatory T Cell Activity.
PLoS One
; 11(6): e0156643, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27284967
7.
Effect of cisplatin treatment on speckled distribution of a serine/arginine-rich nuclear protein CROP/Luc7A.
Biochem Biophys Res Commun
; 301(2): 324-9, 2003 Feb 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-12565863
Resultados
1 -
7
de 7
1
Próxima >
>>